Get Started
Investor Relations
Building the infrastructure
for surgical decision-making.

WhiteGloveMD combines proprietary AI with world-class physician expertise to deliver the most comprehensive cardiac surgery decision support platform in the world.

475K+
open heart surgeries per year in the U.S. alone
<2%
of patients get a second opinion before cardiac surgery
70%+
of care plans change after an independent expert review

The opportunity.

Cardiac surgery is a $40B+ annual market in the United States. Despite the life-altering nature of these procedures, fewer than 2% of patients receive a meaningful second opinion. WhiteGloveMD addresses this gap with a three-pronged approach: direct-to-consumer second opinions, concierge cardiology subscriptions, and enterprise hospital decision support.

Our proprietary Clintelligence\u2122 AI platform processes medical records through 24 specialized agents, generating structured clinical analysis that is then reviewed and co-signed by two independent physicians. The result is a comprehensive decision support report delivered in 24 hours — not weeks.

Revenue Model
Three revenue streams: per-case second opinion fees ($995–$5,995), monthly concierge subscriptions ($295–$1,995/month), and enterprise annual contracts ($250K–$750K). Unit economics are strong with AI handling the analytical workload at ~$3–5 per case.
Competitive Moat
Proprietary multi-agent AI architecture, dual-physician Heart Team model, clinical defensibility with click-to-proof provenance, and established partnerships with tertiary/quaternary care centers. No other platform combines AI precision with independent physician review at this depth.
Growth Strategy
Direct-to-consumer launch (live), concierge cardiology enrollment (live), enterprise hospital integration (in development). Multi-specialty expansion roadmap includes neurosurgery, thoracic oncology, and complex orthopedics.
Leadership
Founded by a cardiovascular and thoracic surgeon who practiced across top cardiac programs nationally. Clinical advisory board of leading cardiac surgeons and interventional cardiologists.
Interested in learning more?

We welcome conversations with aligned investors who understand the intersection of AI, clinical excellence, and healthcare infrastructure.

Request Materials